Merchant S, Noe LL, Howe A, et al. Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain. Clin Ther. 2013;35(5):659-672. doi:10.1016/j.clinthera.2013.03.016